BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6491288)

  • 1. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    McDaniel LS; Benjamin WH; Forman C; Briles DE
    J Immunol; 1984 Dec; 133(6):3308-12. PubMed ID: 6491288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate.
    Wallick S; Claflin JL; Briles DE
    J Immunol; 1983 Jun; 130(6):2871-5. PubMed ID: 6854020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Nicoletti C
    Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
    Briles DE; Forman C; Hudak S; Claflin JL
    Eur J Immunol; 1984 Nov; 14(11):1027-30. PubMed ID: 6333985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.
    Nicoletti C; Yang X; Cerny J
    J Immunol; 1993 Jan; 150(2):543-9. PubMed ID: 8419487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection.
    Lim PL; Choy WF
    Immunology; 1990 Mar; 69(3):443-8. PubMed ID: 2312167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against pneumococcal C-polysaccharide are not protective.
    Nielsen SV; Sørensen UB; Henrichsen J
    Microb Pathog; 1993 Apr; 14(4):299-305. PubMed ID: 8326853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
    Briles DE; Forman C; Hudak S; Claflin JL
    J Mol Cell Immunol; 1984; 1(5):305-9. PubMed ID: 6336560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.
    Yother J; Forman C; Gray BM; Briles DE
    Infect Immun; 1982 Apr; 36(1):184-8. PubMed ID: 7076292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
    Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subpopulations of antibodies to phosphocholine in human serum.
    Brown M; Schiffman G; Rittenberg MB
    J Immunol; 1984 Mar; 132(3):1323-8. PubMed ID: 6693768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies.
    Saeland E; Vidarsson G; Jonsdottir I
    Microb Pathog; 2000 Aug; 29(2):81-91. PubMed ID: 10906263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae.
    Guo WX; Burger AM; Fischer RT; Sieckmann DG; Longo DL; Kenny JJ
    Int Immunol; 1997 May; 9(5):665-77. PubMed ID: 9184912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immune response to Streptococcus pneumoniae by administration of oral viridans streptococci via phosphorylcholine determinant.
    Miwa Y; Ito HO; Inoue M; Oho T
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):441-8. PubMed ID: 15708320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies from the Lyb-5- B cell subset predominate in the secondary IgG response to phosphocholine.
    Wicker LS; Guelde G; Scher I; Kenny JJ
    J Immunol; 1982 Sep; 129(3):950-3. PubMed ID: 6980926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum.
    Aaberge IS; Hvalbye B; Løvik M
    Microb Pathog; 1996 Aug; 21(2):125-37. PubMed ID: 8844655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.
    Briles DE; Forman C; Horowitz JC; Volanakis JE; Benjamin WH; McDaniel LS; Eldridge J; Brooks J
    Infect Immun; 1989 May; 57(5):1457-64. PubMed ID: 2707854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.